Effect of estrogen on osteogenic differentiation and microRNAs expression in rat bone marrow mesenchymal stem cells

doi:10.3877/cma.j.issn.1674-1366.2017.01.004

Abstract

Abstract:

Objective

To investigate the effect of estrogen on osteogenic differentiation and the expression levels of miR-20a, miR-29a in rat bone marrow mesenchymal stem cells (BMSCs) .

Methods

BMSCs were isolated and cultured, and were divided into 3 groups; Blank control group was cultured in complete medium and was named CM group; Control group was cultured in osteogenic differentiation medium and was named OM group; Treatment group was cultured in osteogenic differentiation medium containing 17β-estradiol (E2) and was named E2 group. Cells′ alkaline phosphatase activities were detected after being incubated for 1, 5, 9 days and the expression levels of osteogenic related proteins such as Runt-related transcription factor 2 (RUNX2) , bone morphogenetic protein 2 (BMP2) , Osteopontin (OPN) were detected in day 5 and 9 by western blot. Expression levels of miR-20a-5p, miR-29a-3p were detected in day 5 and 9 by quantitative polymerase chain reaction (qPCR) . The production of mineralized nodule were stained by Alizarin Red in day 19. The t test was used to compare differences between 2 groups and the One-Way ANOVA was used to compare differences among more than 2 groups. P<0.05 was considered statistically significant.

Results

Alp activities: In day 1, the figures were low in every group and there were no significant differences between each group (CM_{1 d}: 3.49, OM_{1 d}: 2.82, E2_{1 d}: 2.92; F= 2.002, P= 0.216) ; In day 5, the alp activities in OM group and E2 group raised markedly (E2_{1 d}: 2.92, E2_{5 d}: 15.83; t= 5.065, P= 0.007; OM_{1 d}: 2.82, OM_{5 d}: 8.38; t= 13.39, P= 0.0002) ; The figure in E2 group was significantly twice as in OM group and was four times as in CM group (F= 13.95, P= 0.0055) ; In day 9, alp activities increased significantly by 3 folds in all the groups compared with the figures in day 5 (CM_{9 d}: 14.66, OM_{9 d}: 22.17, E2_{9 d}: 45.99; CM: t= 11.830, P= 0.0003; OM: t= 8.068, P= 0.0013; E2: t= 9.332, P= 0.0007) ; The figure in OM group was 1.5 times as in CM group and the figure in E2 group was 2 times as in OM group (F= 119.1, P<0.0001) . In day 5 and 9, the expression levels of osteogenic related protein in E2 group were higher than OM or CM group. In day 19, E2 group produced more mineral nodules than OM group. The expression levels of miR-20a-5p in E2 group were high than OM group, increasing by 2 folds and 1.5 folds in day 5 and day 9 respectively (day 5: Mann-Whitney U= 20.000, P= 0.013; Mann-Whitney U= 32.000, P= 0.079) . However, the expression levels of miR-29a-3p did not have significant changes between different groups in these two time points (day 5: Mann-Whitney U= 0.000, P>0.999, Mann-Whitney U= 10.000, 9 d: P= 0.680) .

Conclusions

E2 promoted the osteogenic differentiation in rat BMSCs, and the expression level of miR-20a-5p increased during this process.

Key words: Estradiol, Rats, Mesenchymal stem cells, Osteogenic differentiation, MicroRNA

Guanqi Liu, Zhihui Mai, Jinhua Huang, Lin Chen, Qi Chen, Zheng Chen, Hong Ai. Effect of estrogen on osteogenic differentiation and microRNAs expression in rat bone marrow mesenchymal stem cells[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2017, 11(01): 17-24.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhkqyxyjzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-1366.2017.01.004

https://zhkqyxyjzz.cma-cmc.com.cn/EN/Y2017/V11/I01/17

Figures/Tables 6

References 33

[1]	Cauley JA. Estrogen and bone health in men and women[J]. Steroids，2015，99(Pt A):11-15.
[2]	Rickard DJ, Subramaniam M, Spelsberg TC. Molecular and cellular mechanisms of estrogen action on the skeleton[J]. J Cell Biochem，1999，76(Suppl 32-33):123-132.
[3]	Klein-Nulend J, van Oers RF, Bakker AD，et al. Bone cell mechanosensitivity，estrogen deficiency，and osteoporosis[J]. J Biomech，2015，48(5):855-865.
[4]	Riggs BL, Khosla S, Melton LR. A unitary model for involutional osteoporosis：estrogen deficiency causes both typeⅠ and typeⅡ osteoporosis in postmenopausal women and contributes to bone loss in aging men[J]. J Bone Miner Res，1998，13(5):763-773.
[5]	Rozenberg S, Vandromme J, Antoine C. Postmenopausal hormone therapy：risks and benefits[J]. Nat Rev Endocrinol，2013，9(4):216-227.
[6]	Kim RY, Yang HJ, Song YM，et al. Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway[J]. Tissue Eng Part A，2015，21(13-14):2076-2088.
[7]	Yao XL, Li L, He XL，et al. Activation of β-catenin stimulated by mechanical strain and estrogen requires estrogen receptor in mesenchymal stem cells（MSCs）[J]. Eur Rev Med Pharmacol Sci，2014，18(21):3149-3155.
[8]	Chen J, Qiu M, Dou C，et al. MicroRNAs in Bone Balance and Osteoporosis[J]. Drug Dev Res，2015，76(5):235-245.
[9]	Zhang JF, Fu WM, He ML，et al. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling[J]. RNA Biol，2011，8(5):829-838.
[10]	Roberto VP, Tiago DM, Silva IA，et al. MiR-29a is an enhancer of mineral deposition in bone-derived systems[J]. Arch Biochem Biophys，2014(564):173-183.
[11]	Passos JS, Vianna MI, Gomes-Filho IS，et al. Osteoporosis/osteopenia as an independent factor associated with periodontitis in postmenopausal women：a case-control study[J]. Osteoporos Int，2013，24(4):1275-1283.
[12]	Dodd DZ, Rowe DJ. The relationship between postmenopausal osteoporosis and periodontal disease[J]. J Dent Hyg，2013，87(6):336-344.
[13]	Tera Tde M, Prado RF, De Marco AC，et al. The RANK/RANKL/OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency[J]. Braz Oral Res，2014，28(1):1-9.
[14]	Fujiwara Y, Piemontese M, Liu Y，et al. RANKL（Receptor Activator of NFκB Ligand）Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice[J]. J Biol Chem，2016，291(48):24838-24850.
[15]	Kassem M, Harris SA, Spelsberg TC，et al. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors[J]. J Bone Miner Res，1996，11(2):193-199.
[16]	Kimble RB, Srivastava S, Ross FP，et al. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production[J]. J Biol Chem，1996，271(46):28890-28897.
[17]	Yin X, Wang X, Hu X，et al. ERβ induces the differentiation of cultured osteoblasts by both Wnt/β-catenin signaling pathway and estrogen signaling pathways[J]. Exp Cell Res，2015，335(1):107-114.
[18]	Wade-Gueye NM, Boudiffa M, Vanden-Bossche A，et al. Absence of bone sialoprotein（BSP）impairs primary bone formation and resorption：the marrow ablation model under PTH challenge[J]. Bone，2012，50(5):1064-1073.
[19]	Komori T. Regulation of osteoblast differentiation by Runx2[J]. Adv Exp Med Biol，2010(658):43-49.
[20]	Hong L, Colpan A, Peptan IA. Modulations of 17-beta estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells[J]. Tissue Eng，2006，12(10):2747-2753.
[21]	Zhou S, Zilberman Y, Wassermann K，et al. Estrogen modulates estrogen receptor alpha and beta expression，osteogenic activity，and apoptosis in mesenchymal stem cells（MSCs）of osteoporotic mice[J]. J Cell Biochem Suppl，2001(Suppl 36):144-155.
[22]	Pangas SA. Bone morphogenetic protein signaling transcription factor（SMAD）function in granulosa cells[J]. Mol Cell Endocrinol，2012，356(1-2):40-47.
[23]	Chen G, Deng C, Li YP. TGF-β and BMP signaling in osteoblast differentiation and bone formation[J]. Int J Biol Sci，2012，8(2):272-288.
[24]	Komori T. Regulation of osteoblast differentiation by transcription factors[J]. J Cell Biochem，2006，99(5):1233-1239.
[25]	Cho HJ, Cho HJ, Kim HS. Osteopontin：a multifunctional protein at the crossroads of inflammation，atherosclerosis，and vascular calcification[J]. Curr Atheroscler Rep，2009，11(3):206-213.
[26]	Chen N, Sui BD, Hu CH，et al. microRNA-21 Contributes to Orthodontic Tooth Movement[J]. J Dent Res，2016，95(12):1425-1433.
[27]	Yang M, Pan Y, Zhou Y. miR-96 promotes osteogenic differentiation by suppressing HBEGF-EGFR signaling in osteoblastic cells[J]. FEBS Lett，2014，588(24):4761-4768.
[28]	Mizuno Y, Yagi K, Tokuzawa Y，et al. miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation[J]. Biochem Biophys Res Commun，2008，368(2):267-272.
[29]	Wei J, Shi Y, Zheng L，et al. miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2[J]. J Cell Biol，2012，197(4):509-521.
[30]	Kim KM, Park SJ, Jung S，et al. miR-182 is a negative regulator of osteoblast proliferation，differentiation，and skeletogenesis through targeting FoxO1[J]. J Bone Miner Res，2012，27(8):1669-1679.
[31]	Concepcion CP, Bonetti C, Ventura A. The microRNA-17-92 family of microRNA clusters in development and disease[J]. Cancer J，2012，18(3):262-267.
[32]	Sun Q, Mao S, Li H，et al. Role of miR-17 family in the negative feedback loop of bone morphogenetic protein signaling in neuron[J]. PLoS One，2013，8(12):e83067.
[33]	Wang J, Greene SB, Bonilla-Claudio M，et al. Bmp signaling regulates myocardial differentiation from cardiac progenitors through a MicroRNA-mediated mechanism[J]. Dev Cell，2010，19(6):903-912.

组别	样本量	1d	5d	9d
CM组	3	3.49 ± 0.43	4.25 ± 0.86	14.66 ± 0.17
OM组	3	2.82 ± 0.10	8.38 ± 0.40	22.17 ± 1.66
E2组	3	2.92 ± 0.06	15.83 ± 2.55	45.99 ± 1.99
F值	?	2.002	13.95	119.1
P值	?	0.216	0.0055	< 0.0001

组别	样本量	1d	5d	9d
CM组	3	3.49 ± 0.43	4.25 ± 0.86	14.66 ± 0.17
OM组	3	2.82 ± 0.10	8.38 ± 0.40	22.17 ± 1.66
E2组	3	2.92 ± 0.06	15.83 ± 2.55	45.99 ± 1.99
F值	?	2.002	13.95	119.1
P值	?	0.216	0.0055	< 0.0001

Please choose a citation manager

Content to export